Veralto Corporation (NYSE:VLTO) Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. boosted its position in Veralto Corporation (NYSE:VLTO) by 3.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 14,544 shares of the company’s stock after acquiring an additional 429 shares during the period. Assenagon Asset Management S.A.’s holdings in Veralto were worth $1,417,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in VLTO. Terra Alpha Investments LLC boosted its holdings in shares of Veralto by 4.8% in the 1st quarter. Terra Alpha Investments LLC now owns 19,198 shares of the company’s stock valued at $1,871,000 after purchasing an additional 871 shares during the last quarter. SG Americas Securities LLC grew its holdings in shares of Veralto by 77.1% during the 1st quarter. SG Americas Securities LLC now owns 51,553 shares of the company’s stock worth $5,024,000 after purchasing an additional 22,449 shares during the period. Avanza Fonder AB increased its position in Veralto by 14.1% during the 1st quarter. Avanza Fonder AB now owns 24,552 shares of the company’s stock worth $2,423,000 after purchasing an additional 3,026 shares in the last quarter. Yousif Capital Management LLC increased its position in shares of Veralto by 26.9% in the first quarter. Yousif Capital Management LLC now owns 37,754 shares of the company’s stock worth $3,679,000 after acquiring an additional 7,992 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its stake in shares of Veralto by 12.8% in the 1st quarter. Farther Finance Advisors LLC now owns 2,938 shares of the company’s stock valued at $287,000 after acquiring an additional 333 shares during the period. Hedge funds and other institutional investors own 91.28% of the company’s stock.

Insider Buying and Selling

In other Veralto news, CEO Jennifer Honeycutt sold 10,414 shares of the business’s stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $98.56, for a total transaction of $1,026,403.84. Following the sale, the chief executive officer now directly owns 116,637 shares in the company, valued at approximately $11,495,742.72. The trade was a 8.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Surekha Trivedi sold 848 shares of the firm’s stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $100.55, for a total transaction of $85,266.40. Following the transaction, the senior vice president now owns 8,433 shares in the company, valued at $847,938.15. This represents a 9.14% decrease in their position. The disclosure for this sale can be found here. Insiders sold 56,917 shares of company stock valued at $5,423,033 in the last three months. 0.36% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have commented on VLTO. Northcoast Research assumed coverage on Veralto in a research report on Tuesday, May 6th. They issued a “buy” rating and a $110.00 price objective on the stock. Robert W. Baird upped their price target on Veralto from $105.00 to $106.00 and gave the stock a “neutral” rating in a report on Thursday, May 1st. Stifel Nicolaus lifted their price objective on shares of Veralto from $102.00 to $104.00 and gave the company a “buy” rating in a research note on Thursday, May 1st. Citigroup decreased their target price on shares of Veralto from $116.00 to $100.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Finally, Royal Bank Of Canada boosted their price objective on shares of Veralto from $103.00 to $104.00 and gave the stock a “sector perform” rating in a report on Thursday, May 1st. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $110.09.

Veralto Price Performance

Shares of VLTO opened at $97.41 on Wednesday. The stock has a 50 day moving average of $96.48 and a 200-day moving average of $98.92. Veralto Corporation has a 52 week low of $83.87 and a 52 week high of $115.00. The firm has a market cap of $24.14 billion, a price-to-earnings ratio of 27.83, a PEG ratio of 4.21 and a beta of 0.97. The company has a current ratio of 2.19, a quick ratio of 1.92 and a debt-to-equity ratio of 1.14.

Veralto (NYSE:VLTO) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.08. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.28 billion. Veralto had a net margin of 16.56% and a return on equity of 45.63%. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.84 EPS. As a group, analysts forecast that Veralto Corporation will post 3.66 EPS for the current year.

Veralto Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.11 per share. The ex-dividend date is Monday, June 30th. This represents a $0.44 annualized dividend and a dividend yield of 0.45%. Veralto’s dividend payout ratio is presently 12.57%.

Veralto Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.